Publications
32 publications
Funding
8 grants
Active
2 grants- PIEPEF 260435-01Dissecting the molecular determinants of MDS transformation in VEXAS syndromeEdward P. Evans Foundation · 2026–2029
- PIASH 233301-03Integrated single-cell multi-omics approaches to identify therapeutic vulnerabilities in VEXAS syndromeAmerican Society of Hematology Inc · 2024–2027
Completed grants (6)
- KPHCL8028-22Developing Novel Therapeutic Approaches for Classical and Variant Hairy Cell Leukemia (Core 2)Leukemia & Lymphoma Society · 2021–2025 · via Memorial Sloan Kettering Cancer Center
- KPR33CA267219-01A1Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypesNational Cancer Institute · 2022–2025
- KPR01HL130996-05Mosaic: post-zygotic mutations in vascular and lymphatic developmental disorders.National Heart, Lung, and Blood Institute · 2020–2025 · via Seattle Children's Hospital
- KPI15-0028Defining the evolutionary mechanisms of IDH-mutant glioma progression through single-cell multi-omics innovationStarr Cancer Consortium · 2022–2023
- KPNYUSM 2-A0-00-1007627,Genome of Transcriptome (GoT) to study CHIP Inflammation in AtherosclerosisChan Zuckerberg Initiative · 2021–2022 · via New York University School of Medicine (Grossman)
- KPMSSM 2020-218415Genome of Transcriptome (GoT) to study CHIP Inflammation in AtherosclerosisChan Zuckerberg Initiative · 2020–2021 · via Mount Sinai School of Medicine
News mentions
1 mentionView all WCM news ↗
- GoT-ChA: A New Tool for Detailing How Gene Mutations Affect CellsMay 8, 2024
A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA.